Items tagged with Drug-resistant TB
WHO/Europe: Request for submission of good practices in health systems strengthening for prevention and care of M/XDR-Tuberculosis (TB) (post)
In September 2011 the Consolidated Action Plan to Prevent and Combat Multidrug- and Extensively Drug-Resistant Tuberculosis in the WHO European Region, 2011–2015 and its accompanying resolution EUR/R61/R7 were endorsed at the sixty-first session of the Regional Committee (Baku, Azerbaijan, 12–15 September 2011).
ECDC welcomes the endorsement of the global action plan on antimicrobial resistance by the World Health Assembly (post)
On 25 May, delegates from the World Health Assembly, the decision-making body of the World Health Organisation (WHO), endorsed a global action plan to tackle antimicrobial resistance. The goal of this action plan is to ensure successful treatment and prevention of infectious diseases by securing fair, affordable access to effective antimicrobial agents to those who need it most.
What needs to be added to South Africa’s anti-TB toolbox (post)
The approval in South Africa last year of the first new TB drug in 50 years was celebrated as a milestone in the fight against the global epidemic.
Impact of decentralized care and the Xpert MTB/RIF test on rifampicin-resistant tuberculosis treatment initiation in Khayelitsha, South Africa (post)
Abstract
Four decades of transmission of a multidrug-resistant Mycobacterium tuberculosis outbreak strain (post)
Abstract
XDR-TB patient in U.S. highlights global reach of infectious disease (post)
If an argument is needed against prioritizing United States medical research dollars simply on the basis of disease burden in the U.S., global health advocates in Washington, DC didn’t have to look any farther this week than the National Institutes of Health campus in Maryland. That’s where a woman who recently flew from India to Chicago and has since been diagnosed with extensively drug-resistant tuberculosis is now being treated.
South Africa: More than R130 million slated for new TB drugs (post)
In just four years, South Africa has seen a 40-fold increase in health facilities treating drug-resistant tuberculosis (DR-TB) as government pledges more than R130 million for new medicines.
Ukraine has started clinical trials of pretomanid (post)
This was reported on May 28, 2015 during a round table at UKRINFORM agency in Kiev “New treatment regimens for Drug-Resistant TB, based on the newest available drugs” organised by Public Movement “Ukrainians against TB” and the Yanovsky National TB Institute, by head of the TB Institute Department of Chemo-resistant TB Svetlana Cherenko.
Fluoroquinolone preventive therapy deemed beneficial in TB (post)
WEDNESDAY, June 17, 2015 -- Fluoroquinolone therapy for contacts of individuals with multidrug-resistant tuberculosis is associated with cost savings and reduced incidence of multidrug-resistant tuberculosis, according to a study published online April 27 in the American Journal of Respiratory and Critical Care Medicine.
Philanthropists unite to accelerate global fight against tuberculosis with combined $20 million gift to Broad Institute (post)
Cambridge, Mass. June 22nd, 2015 — With deadly drug-resistant strains of tuberculosis on the rise, more than 20 philanthropists from New York and Boston have come together to fund a $20 million project at the Broad Institute of MIT and Harvard to help combat the global epidemic.
Page 16 of 117 · Total posts: 0
←First 15 16 17 Last→